Immunotherapeutic nanoparticles: From autoimmune disease control to the development of vaccines

The development of nanoparticles (NPs) with potential therapeutic uses represents an area of vast interest in the scientific community during the last years. Recently, the pandemic caused by COVID-19 motivated a race for vaccines creation to overcome the crisis generated. This is a good demonstratio...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitarotonda, Romina, Giorgi, Exequiel, Eufrasio-da-Silva, Tatiane, Dolatshahi-Pirouz, Alireza, Mishra, Yogendra Kumar, Khademhosseini, Ali, Desimone, Martin F., De Marzi, Mauricio, Orive, Gorka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023085/
https://www.ncbi.nlm.nih.gov/pubmed/35475005
http://dx.doi.org/10.1016/j.bioadv.2022.212726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023085/
https://www.ncbi.nlm.nih.gov/pubmed/35475005
http://dx.doi.org/10.1016/j.bioadv.2022.212726

Ejemplares similares